Carcinotech
PrivateLast Round
Early Funding
Jan 29, 2024
Total Funding Raised
$7.4M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Carcinotech is a medical technology company that provides 3D printed living tumors using patient-derived biopsies for drug screening, pre-clinical testing, and personalized medicine.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, 3D Printing, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Carcinotech Comparables
Compare Carcinotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cypre Inc. | 88% | |
| TissueTinker Bio | 84% | |
| Keliomics | 82% |
Carcinotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jan 29, 2024 | ||||
| Seed | Apr 25, 2022 |
Key People
Founding team and executive leadership
Carcinotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Investing Women Angels | Early Funding |
| Gabriel Investments Ltd | Early Funding, Seed |
| British Business Bank | Early Funding |
| Old College Capital | Early Funding, Pre Seed |
| The TRICAPITAL Syndicate | Early Funding, Seed |
| Eos Advisory | Seed, Early Funding |
| Gabriel Investments | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 39% MoM.
- Jan 29, 2024
$5.3M raised, led by Eos Advisory.
Carcinotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Carcinotech's valuation, stock price, and market status.
Is Carcinotech a public or private company?
Carcinotech is a private company.
What is the current stock price of Carcinotech?
Carcinotech is a private company with no public stock price. No recent secondary market data is available.
How much is Carcinotech worth (valuation)?
Valuation information for Carcinotech is not publicly available.
Can I buy Carcinotech stock?
Carcinotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Carcinotech's last funding round?
Carcinotech's most recent funding round was Pre Seed on January 29, 2024.
Who are the main investors in Carcinotech?
Key investors in Carcinotech include The TRICAPITAL Syndicate, Eos Advisory.
Will Carcinotech IPO soon?
No public IPO plans have been announced for Carcinotech.
How can I track Carcinotech secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Carcinotech's secondary market activity and sign up for updates.